Melanoma

Melanoma Jeffrey E. Gershenwald Oncologist 2001; 6: 402-406 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine regarding melanomas and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Understand the patterns of failure after sentinel lymph node biopsy. Appreciate the rationale for maintenance therapy following biochemotherapy. Understand the results of recent adjuvant therapy trials employing interferon in melanoma. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Mar. 20, 2002 Most Recent Review: Mar. 16, 2005* Most Recent Update: Mar. 16, 2005 Date Credit Expires: Apr. 12, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.